Associate Professor

Robert Henderson

Email: 
Phone: 
+61 7 334 65011

Availability

Associate Professor Robert Henderson is:
Available for supervision

Search Professor Robert Henderson’s works on UQ eSpace

231 works between 1998 and 2025
All (231) Journal Article (191) Other Outputs (2) Conference Publication (35) Book Chapter (3)

81 - 100 of 231 works

2019

Journal Article

Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis

Ngo, Shyuan T., Van Eijk, Ruben P. A., Chachay, V. , Van Den Berg, Leonard H., Mccombe, Pamela A., Henderson, Robert D. and Steyn, Frederik J. (2019). Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 20 (7-8), 1-9. doi: 10.1080/21678421.2019.1621346

Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis

2019

Journal Article

Gut microbiota in ALS: possible role in pathogenesis?

McCombe, Pamela A., Henderson, Robert D., Lee, Aven, Lee, John D., Woodruff, Trent M., Restuadi, Restuadi, McRae, Allan, Wray, Naomi R., Ngo, Shyuan and Steyn, Frederik J. (2019). Gut microbiota in ALS: possible role in pathogenesis?. Expert Review of Neurotherapeutics, 19 (9), 1-21. doi: 10.1080/14737175.2019.1623026

Gut microbiota in ALS: possible role in pathogenesis?

2019

Journal Article

Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies

Merkies, Ingemar S.J., van Schaik, Ivo N., Léger, Jean-Marc, Bril, Vera, van Geloven, Nan, Hartung, Hans-Peter, Lewis, Richard A., Sobue, Gen, Lawo, John-Philip, Durn, Billie L., Cornblath, David R., De Bleecker, Jan L., Sommer, Claudia, Robberecht, Wim, Saarela, Mika, Kamienowski, Jerzy, Stelmasiak, Zbigniew, Tackenberg, Björn, Mielke, Orell, Sabet, A., George, K., Roberts, L., Carne, R., Blum, S., Henderson, R., Van Damme, P., Demeestere, J., Larue, S., D'Amour, C. ... Zwolińska, G. (2019). Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies. Journal of the Peripheral Nervous System, 24 (1), 48-55. doi: 10.1111/jns.12302

Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies

2019

Journal Article

Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra study

Mielke, Orell, Bril, Vera, Cornblath, David R., Lawo, John-Philip, van Geloven, Nan, Hartung, Hans-Peter, Lewis, Richard A., Merkies, Ingemar S.J., Sobue, Gen, Durn, Billie, Shebl, Amgad, van Schaik, Ivo N., Sabet, A., George, K., Roberts, L., Carne, R., Blum, S., Henderson, R., Van Damme, P., Demeestere, J., Larue, S., D'Amour, C., Kunc, P., Valis, M., Sussova, J., Kalous, T., Talab, R., Bednar, M., Toomsoo, T. ... Gable, K. (2019). Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra study. Journal of the Peripheral Nervous System, 24 (1), 72-79. doi: 10.1111/jns.12303

Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra study

2019

Journal Article

Tract integrity in amyotrophic lateral sclerosis: 6–month evaluation using MR diffusion tensor imaging

Alruwaili, Ashwag R., Pannek, Kerstin, Henderson, Robert D., Gray, Marcus, Kurniawan, Nyoman D. and McCombe, Pamela A. (2019). Tract integrity in amyotrophic lateral sclerosis: 6–month evaluation using MR diffusion tensor imaging. BMC Medical Imaging, 19 (1) 19, 19. doi: 10.1186/s12880-019-0319-3

Tract integrity in amyotrophic lateral sclerosis: 6–month evaluation using MR diffusion tensor imaging

2018

Journal Article

Intravenous versus subcutaneous immunoglobulin – Authors' reply

van Schaik, Ivo N, Mielke, Orell, Sabet, Arman, George, Koshy, Roberts, Leslie, Carne, Ross, Blum, Stefan, Henderson, Robert, Van Damme, Philip, Demeestere, Jelle, Larue, Sandrine, Pinard D'Amour, Catherine-Andree, Bril, Vera, Breiner, Ari, Kunc, Pavel, Valis, Martin, Sussova, Jana, Kalous, Tomas, Talab, Radomir, Bednar, Michal, Toomsoo, Toomas, Rubanovits, Inna, Gross-Paju, Katrin, Sorro, Ulvi, Saarela, Mika, Auranen, Mari, Pouget, Jean, Attarian, Shahram, Le Masson, Gwendal ... Mielke, Orell (2018). Intravenous versus subcutaneous immunoglobulin – Authors' reply. The Lancet Neurology, 17 (5), 393-394. doi: 10.1016/S1474-4422(18)30109-1

Intravenous versus subcutaneous immunoglobulin – Authors' reply

2018

Journal Article

Hypermetabolism in ALS is associated with greater functional decline and shorter survival

Steyn, Frederik J., Ioannides, Zara A., van Eijk, Ruben P. A., Heggie, Susan, Thorpe, Kathryn A., Ceslis, Amelia, Heshmat, Saman, Henders, Anjali K., Wray, Naomi R., van den Berg, Leonard H., Henderson, Robert D., McCombe, Pamela A. and Ngo, Shyuan T. (2018). Hypermetabolism in ALS is associated with greater functional decline and shorter survival. Journal of Neurology, Neurosurgery, and Psychiatry, 89 (10), jnnp-2017. doi: 10.1136/jnnp-2017-317887

Hypermetabolism in ALS is associated with greater functional decline and shorter survival

2018

Journal Article

Human cerebral evolution and the clinical syndrome of amyotrophic lateral sclerosis

Henderson, Robert D., Garton, Fleur C., Kiernan, Matthew C., Turner, Martin R. and Eisen, Andrew (2018). Human cerebral evolution and the clinical syndrome of amyotrophic lateral sclerosis. JNNP Online, 90 (5), jnnp-2017. doi: 10.1136/jnnp-2017-317245

Human cerebral evolution and the clinical syndrome of amyotrophic lateral sclerosis

2018

Journal Article

A combined tract-based spatial statistics and voxel-based morphometry study of the first MRI scan after diagnosis of amyotrophic lateral sclerosis with subgroup analysis

Alruwaili, A. R., Pannek, K., Coulthard, A., Henderson, R., Kurniawan, N. D. and McCombe, P. (2018). A combined tract-based spatial statistics and voxel-based morphometry study of the first MRI scan after diagnosis of amyotrophic lateral sclerosis with subgroup analysis. Journal of Neuroradiology, 45 (1), 41-48. doi: 10.1016/j.neurad.2017.03.007

A combined tract-based spatial statistics and voxel-based morphometry study of the first MRI scan after diagnosis of amyotrophic lateral sclerosis with subgroup analysis

2018

Journal Article

Mass spectrometry analysis of plasma from amyotrophic lateral sclerosis and control subjects

Xu, Zhouwei, Lee, Aven, Nouwens, Amanda, David Henderson, Robert and Mccombe, Pamela Ann (2018). Mass spectrometry analysis of plasma from amyotrophic lateral sclerosis and control subjects. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 19 (5-6), 1-15. doi: 10.1080/21678421.2018.1433689

Mass spectrometry analysis of plasma from amyotrophic lateral sclerosis and control subjects

2018

Journal Article

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

van Schaik, Ivo N., Bril, Vera, van Geloven, Nan, Hartung, Hans-Peter, Lewis, Richard A., Sobue, Gen, Lawo, John-Philip, Praus, Michaela, Mielke, Orell, Durn, Billie L., Cornblath, David R., Merkies, Ingemar S. J., Sabet, A., George, K., Roberts, L., Carne, R., Blum, S., Henderson, R., Van Damme, P., Demeestere, J., Larue, S., D'Amour, C., Bril, V., Breiner, A., Kunc, P., Valis, M., Sussova, J., Kalous, T., Talab, R. ... on behalf of the PATH study group (2018). Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Neurology, 17 (1), 35-46. doi: 10.1016/S1474-4422(17)30378-2

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

2018

Journal Article

Patient with ALS with a novel TBK1 mutation, widespread brain involvement, behaviour changes and metabolic dysfunction

McCombe, Pamela A., Ngo, Shyuan T., Guo, Christine Cong, Fazlollahi, Amir, Bollmann, Saskia, Wang, Liting, Hu, Xintao, Barth, Markus, Salvado, Olivier, Davis, Mark, Ceslis, Amelia, Robinson, Gail, Henderson, Robert D. and Steyn, Frederik J. (2018). Patient with ALS with a novel TBK1 mutation, widespread brain involvement, behaviour changes and metabolic dysfunction. Journal of Neurology, Neurosurgery and Psychiatry, 90 (8), 952-954. doi: 10.1136/jnnp-2018-318823

Patient with ALS with a novel TBK1 mutation, widespread brain involvement, behaviour changes and metabolic dysfunction

2017

Journal Article

The utility of FDG-PET in complex neurological conditions

Ioannides, Zara A., Thomas, Paul, Langguth, Daman, Kubler, Paul and Henderson, Robert D. (2017). The utility of FDG-PET in complex neurological conditions. Internal Medicine Journal, 47 (12), 1460-1462. doi: 10.1111/imj.13638

The utility of FDG-PET in complex neurological conditions

2017

Journal Article

Cross-ethnic meta-analysis identifies association of the GPX3-TNIP1 locus with amyotrophic lateral sclerosis

Benyamin, Beben, He, Ji, Zhao, Qiongyi, Gratten, Jacob, Garton, Fleur, Leo, Paul J., Liu, Zhijun, Mangelsdorf, Marie, Al-Chalabi, Ammar, Anderson, Lisa, Butler, Timothy J., Chen, Lu, Chen, Xiang-Ding, Cremin, Katie, Deng, Hong-Weng, Devine, Matthew, Edson, Janette, Fifita, Jennifer A., Furlong, Sarah, Han, Ying-Ying, Harris, Jessica, Henders, Anjali K., Jeffree, Rosalind L., Jin, Zi-Bing, Li, Zhongshan, Li, Ting, Li, Mengmeng, Lin, Yong, Liu, Xiaolu ... Fan, Dongsheng (2017). Cross-ethnic meta-analysis identifies association of the GPX3-TNIP1 locus with amyotrophic lateral sclerosis. Nature Communications, 8 (1) 611, 611. doi: 10.1038/s41467-017-00471-1

Cross-ethnic meta-analysis identifies association of the GPX3-TNIP1 locus with amyotrophic lateral sclerosis

2017

Journal Article

Exploring targets and therapies for amyotrophic lateral sclerosis: current insights into dietary interventions

Ngo, Shyuan T., Mi, Jia D., Henderson, Robert D., McCombe, Pamela A. and Steyn, Frederik J. (2017). Exploring targets and therapies for amyotrophic lateral sclerosis: current insights into dietary interventions. Degenerative Neurological and Neuromuscular Disease, 7, 95-108. doi: 10.2147/DNND.S120607

Exploring targets and therapies for amyotrophic lateral sclerosis: current insights into dietary interventions

2017

Journal Article

Whole exome sequencing and DNA methylation analysis in a clinical amyotrophic lateral sclerosis cohort

Garton, Fleur C., Benyamin, Beben, Zhao, Qiongyi, Liu, Zhijun, Gratten, Jacob, Henders, Anjali K., Zhang, Zong-Hong, Edson, Janette, Furlong, Sarah, Morgan, Sarah, Heggie, Susan, Thorpe, Kathryn, Pfluger, Casey, Mather, Karen A., Sachdev, Perminder S., McRae, Allan F., Robinson, Matthew R., Shah, Sonia, Visscher, Peter M., Mangelsdorf, Marie, Henderson, Robert D., Wray, Naomi R. and McCombe, Pamela A. (2017). Whole exome sequencing and DNA methylation analysis in a clinical amyotrophic lateral sclerosis cohort. Molecular Genetics and Genomic Medicine, 5 (4), 418-428. doi: 10.1002/mgg3.302

Whole exome sequencing and DNA methylation analysis in a clinical amyotrophic lateral sclerosis cohort

2017

Journal Article

Predictions of resting energy expenditure in amyotrophic lateral sclerosis are greatly impacted by reductions in fat free mass

Ioannides, Z. A., Steyn, F. J., Henderson, R. D., McCombe, P. A. and Ngo, S. T. (2017). Predictions of resting energy expenditure in amyotrophic lateral sclerosis are greatly impacted by reductions in fat free mass. Cogent Medicine, 4 (1), 1343000. doi: 10.1080/2331205X.2017.1343000

Predictions of resting energy expenditure in amyotrophic lateral sclerosis are greatly impacted by reductions in fat free mass

2017

Journal Article

Extra-motor abnormalities in amyotrophic lateral sclerosis: another layer of heterogeneity

McCombe, P. A., Wray, N. R. and Henderson, R. D. (2017). Extra-motor abnormalities in amyotrophic lateral sclerosis: another layer of heterogeneity. Expert Review of Neurotherapeutics, 17 (6), 561-577. doi: 10.1080/14737175.2017.1273772

Extra-motor abnormalities in amyotrophic lateral sclerosis: another layer of heterogeneity

2017

Journal Article

Screening for cognitive and behavioural impairment in amyotrophic lateral sclerosis: frequency of abnormality and effect on survival

Xu, Zhouwei, Alruwaili, Ashwag Rafea S., Henderson, Robert David and McCombe, Pamela Ann (2017). Screening for cognitive and behavioural impairment in amyotrophic lateral sclerosis: frequency of abnormality and effect on survival. Journal of the Neurological Sciences, 376, 16-23. doi: 10.1016/j.jns.2017.02.061

Screening for cognitive and behavioural impairment in amyotrophic lateral sclerosis: frequency of abnormality and effect on survival

2017

Journal Article

Anthropometric measures are not accurate predictors of fat mass in ALS

Ioannides, Zara A., Steyn, Frederik J., Henderson, Robert D., Mccombe, Pamela A. and Ngo, Shyuan T. (2017). Anthropometric measures are not accurate predictors of fat mass in ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 18 (7-8), 486-491. doi: 10.1080/21678421.2017.1317811

Anthropometric measures are not accurate predictors of fat mass in ALS

Current funding

  • 2024 - 2027
    Predicting functional decline in MND using metabolic body mapping
    Cure for MND Foundation - Impact Grants
    Open grant
  • 2024 - 2026
    AMII: Asia-pacific MND Imaging Initiative (2022 FightMND Collaborative Initiatives Grant administered by The University of Sydney)
    University of Sydney
    Open grant
  • 2023 - 2027
    Save our Speech (SoS) Study: Towards automated speech biomarkers of disease progression and treatment responsiveness in amyotrophic lateral sclerosis (ALS).
    Motor Neurone Disease Research Institute of Australia Inc Innovator Grant
    Open grant

Past funding

  • 2022
    Targeting inflammasome-driven neuropathology and motor neuron death in MND using a clinically approved cancer drug.
    Motor Neurone Disease Research Institute of Australia Inc Linda Rynalski Bridge Funding Grant
    Open grant
  • 2021 - 2022
    Targeting NAT1 to improve metabolism and slow disease progression in MND
    Motor Neurone Disease Research Institute of Australia Inc Innovator Grant
    Open grant
  • 2021 - 2024
    A Novel PET Imaging Market of Astrocytes and Glutamate Reuptake in Brain and Spinal Cord in Amyotrophic Lateral Sclerosis
    Motor Neurone Disease Research Institute of Australia Inc
    Open grant
  • 2021 - 2022
    N-acetyltransferase 1, a modifier of disease outcome in patients with Motor Neurone Disease (MND).
    Metro North Hospital and Health Service
    Open grant
  • 2020 - 2022
    Targeting inflammasome-driven neuropathology and motor neuron death in MND using a clinically approved cancer drug.
    Motor Neurone Disease Research Institute of Australia Inc
    Open grant
  • 2020 - 2021
    Investigating the immunometabolic nature of motor neurone disease (MND): a study linking metabolism, inflammation, and clinical outcomes in MND patients
    Metro North Hospital and Health Service
    Open grant
  • 2020 - 2022
    Development of biomarkers for loss of fat free mass and disease progression in patients with Motor Neurone Disease
    Royal Brisbane and Women's Hospital
    Open grant
  • 2019 - 2020
    Immunogenetics of motor neurone disease - a pilot study
    Motor Neurone Disease Research Institute of Australia Inc
    Open grant
  • 2018 - 2021
    A novel ephrin receptor A4-Fc fusion protein for the treatment of motor neuron disease
    Cure for MND Foundation - Translational Research Grants
    Open grant
  • 2018 - 2019
    Novel biomarkers for motor neurone disease
    Motor Neurone Disease Research Institute of Australia Inc
    Open grant
  • 2018 - 2023
    Motor Neurone Disease: Patient centred care for a progressive neurological disease - evidence driving policy (NHMRC Partnership Project administered by the University of Sydney)
    University of Sydney
    Open grant
  • 2018 - 2019
    Longitudinal assessment of behaviour and cognition in ALS through brief Online Carers' behavioural Questionnaire (OCQ)
    Motor Neurone Disease Research Institute of Australia Inc
    Open grant
  • 2018 - 2019
    Investigating the proteome of MND brains
    Metro North Hospital and Health Service
    Open grant
  • 2018 - 2020
    Use of mass spectrometry to identify circulating toxins in the people with ALS
    Wesley Merdical Research
    Open grant
  • 2018 - 2019
    Use of Point-of-Care (PoC) testing to improve respiratory management and monitor disease progression in ALS: A pilot study
    Metro North Hospital and Health Service
    Open grant
  • 2017 - 2019
    Defining inflammatory biomarkers in motor neuron disease patients to assist in clinical trial efficiency of the C5aR antagonist PMX205
    Wesley Medical Research Ltd
    Open grant
  • 2017
    Discovery of EAAT5 - a protein that may stop glutamate excitotoxicity in ALS
    Motor Neurone Disease Research Institute of Australia Inc
    Open grant
  • 2017 - 2018
    Metabolic exploration in neurodegenerative disease (MEND): synergy between derangements in systemic and muscle metabolism in MND
    Motor Neurone Disease Research Institute of Australia Inc
    Open grant
  • 2016
    Metabolic and gut dynamics in MND: Identifying novel strategies to meet energy needs in patients
    Motor Neurone Disease Research Institute of Australia Inc
    Open grant
  • 2016
    Using biomarkers to explore heterogeneity of motor neurone disease
    Motor Neurone Disease Research Institute of Australia Inc
    Open grant
  • 2015
    A multicentre study of the impact of metabolic balance and dietary intake on the clinical parameters of disease progression
    Motor Neurone Disease Research Institute of Australia Inc
    Open grant
  • 2015
    Blood biomarkers in ALS: Translation into clinical practice of pNfH and search for additional biomarkers using proteomics
    Motor Neurone Disease Research Institute of Australia Inc
    Open grant
  • 2015
    Mass spectrometry to search for biomarkers in motor neurone disease
    Royal Brisbane and Women's Hospital
    Open grant
  • 2015
    The role of altered neuromuscular activity and mRNA transport in modifying the progression of Motor Neuron Disease
    Royal Brisbane and Women's Hospital Foundation
    Open grant
  • 2015
    The role of altered neuronal activity and mRNA transport in modifying the progression Motor Neuron Disease (MND)
    Royal Brisbane and Women's Hospital Foundation
    Open grant
  • 2014
    Targeting EphA4 as a treatment for MND
    Motor Neurone Disease Research Institute of Australia Inc
    Open grant
  • 2014 - 2015
    The role of altered neuromuscular signaling in ALS: factors that modify the course of MND
    Motor Neurone Disease Research Institute of Australia Inc
    Open grant
  • 2014 - 2015
    Whole exome sequencing of sporadic MND
    Motor Neurone Disease Research Institute of Australia Inc
    Open grant
  • 2013 - 2014
    Biomarkers of disease progression in MND
    UQ Academic Title Holder Research Fund
    Open grant
  • 2013
    Use of biomarkers to understand Amyotrophic Lateral Sclerosis
    Motor Neurone Disease Research Institute of Australia Inc
    Open grant
  • 2013
    Using biomarkers to assess disease progression and understanding of MND
    Royal Brisbane and Women's Hospital
    Open grant
  • 2012 - 2013
    Blood Biomarkers in Motor Neurone Disease
    Royal Brisbane and Women's Hospital
    Open grant
  • 2012
    MND - not a simple disease
    Motor Neurone Disease Research Institute of Australia Inc
    Open grant
  • 2011
    Comprehensive assessment of MND patients as a means to studying progression and identifying disease subtypes
    Motor Neurone Disease Research Institute of Australia Inc
    Open grant
  • 2011 - 2013
    Nature and timing of inflammation after acute ischaemic stroke
    National Heart Foundation of Australia
    Open grant
  • 2009 - 2012
    Development of a new method of motor unit number estimation for use in motor neurone disease
    NHMRC Project Grant
    Open grant
  • 2009 - 2010
    Identifying biomarkers for MND using flow cytometry.
    Motor Neurone Disease Research Institute of Australia Inc
    Open grant
  • 2008 - 2011
    Clinical efficacy and physiological mechanisms of nerve and tendon gliding exercises for carpal tunnel syndrome.
    NHMRC Project Grant
    Open grant
  • 2005 - 2006
    Supplementary funding to advance development
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2002 - 2004
    Motor Unit Analysis in Motor Neurone Disease
    Motor Neurone Disease Association Queensland Inc
    Open grant

Availability

Associate Professor Robert Henderson is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Supervision history

Current supervision

Completed supervision

Enquiries

For media enquiries about Associate Professor Robert Henderson's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au